Executive Summary
This digest covers five significant civilian contract modifications totaling $1,718,415,049 in obligations, with 0/5 defense-related awards across DOE, USDA, HHS, GSA, and DHS. Dominant themes include strategic nuclear materials production (DOE/ORANO $900M) and IT/software services (USDA/Carahsoft $295M), underscoring civilian agency commitments to energy security and enterprise tech upgrades.
Highest-conviction bullish signal is Carahsoft Technology Corp's fully obligated and outlayed $294.6M USDA Salesforce contract (strength 8/10), signaling reliable revenue through 2025. Key risk is high pricing risk on firm-fixed-price structures across top awards (ORANO, Carahsoft, GLOBAL HEALTH), with watch on initial outlays for ORANO's LEU production post-May 2026 start.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from May 01, 2026.
Investment Signals (5)
- ORANO FEDERAL SERVICES LLC Secures $900M DOE LEU Production Order (HIGH)▲
DOE Idaho Operations Office awarded $900M firm-fixed-price delivery order to ORANO for domestic low-enriched uranium capacity establishment, spanning 7 years to 2033 with full obligation and $0 outlayed to date under full/open competition.
- Carahsoft Technology Corp's $295M USDA Salesforce Contract Fully Executed (HIGH)▲
USDA Office of Chief Financial Officer fully obligated and outlayed $294.6M firm-fixed-price order to Carahsoft for enterprise-wide Salesforce software/support, completing 5-year performance to June 2025.
- Bank of New York Mellon Lands $244M GSA Ginnie Mae Securities Contract (MEDIUM)▲
GSA awarded $244M firm-fixed-price contract (base+options to $871M) to Bank of New York Mellon for mortgage-backed securities issuance/administration, with $189M outlayed to date through potential 2030.
- GLOBAL HEALTH INVESTMENT CORPORATION's $270M HHS BARDA R&D OTA Nears Completion (MEDIUM)▲
HHS/ASPR awarded $270M firm-fixed-price OTA to nonprofit GLOBAL HEALTH INVESTMENT CORPORATION for health preparedness R&D, with $242M (90%) outlayed over 10+ year period to potential 2041.
- Lockheed Martin Adds Modest $9.4M DHS Coast Guard C4ISR Lab Services (LOW)▲
DHS Coast Guard sole-sourced $9.4M cost-plus-fixed-fee contract (options to $10.6M) to Lockheed Martin for C4ISR integration/test lab services through 2027, with $0 outlayed to date.
Risk Flags (2)
- Execution [HIGH RISK]▼
High pricing risk on firm-fixed-price structures for ORANO FEDERAL SERVICES LLC ($900M DOE), Carahsoft ($295M USDA), and GLOBAL HEALTH ($270M HHS), with potential non-uniform ramp-up for ORANO's LEU capacity.
- Budget [MEDIUM RISK]▼
$0 outlayed to date on ORANO $900M DOE and Lockheed Martin $9.4M DHS contracts signals delayed funding execution amid civilian budget cycles.
Opportunities (3)
- ◆
Carahsoft Technology Corp's USDA Salesforce contract ends June 2025, positioning for follow-on awards in agriculture IT modernization.
- ◆
Bank of New York Mellon's GSA contract has $871M base+options potential to 2030, with $627M unexercised beyond current $244M obligation.
- ◆
GLOBAL HEALTH INVESTMENT CORPORATION's HHS BARDA OTA has potential extension to 2041-06-01 beyond current 2031 end, with $28M remaining obligation.
Sector Themes (3)
- ◆
DOE's $900M award to ORANO FEDERAL SERVICES LLC establishes domestic LEU production capacity through 2033, signaling policy-driven commitment to strategic nuclear materials.
- ◆
USDA's fully executed $295M Carahsoft Salesforce order and DHS $9.4M Lockheed C4ISR lab services highlight enterprise software and data center investments.
- ◆
HHS/BARDA's $270M OTA to GLOBAL HEALTH INVESTMENT CORPORATION, 90% outlayed with 20-year potential, underscores sustained nonprofit funding for basic health R&D.
Watch List (5)
- 👁
{"entity"=>"ORANO FEDERAL SERVICES LLC", "reason"=>"$900M DOE LEU contract with $0 outlayed and 7-year ramp-up for capacity establishment", "trigger"=>"initial outlays post-2026-05-01; performance milestones to 2033-04-30"}
- 👁
{"entity"=>"Carahsoft Technology Corp", "reason"=>"$295M USDA Salesforce fully outlayed nearing 2025 end", "trigger"=>"performance end date 2025-06-19 for follow-on awards"}
- 👁
{"entity"=>"Bank of New York Mellon", "reason"=>"$244M GSA obligation with $189M outlayed and $871M options potential", "trigger"=>"option exercise; current end 2026-06-30 to potential 2030-12-31"}
- 👁
{"entity"=>"GLOBAL HEALTH INVESTMENT CORPORATION", "reason"=>"$270M HHS with $28M remaining and long-term extension potential", "trigger"=>"outlay progress; 2031-06-01 current end or 2041 extension"}
- 👁
{"entity"=>"Lockheed Martin Corporation", "reason"=>"$9.4M DHS with $0 outlayed and sole-source structure", "trigger"=>"funds outlay; $1.15M option exercise by 2027-05-03"}
Get daily alerts with 5 investment signals, 2 risk alerts, 3 opportunities and full AI analysis of all 5 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Significant Contract Modifications ($10M+)
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals